Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
2 No-Brainer Healthcare Stocks to Buy With $500 Right Now
05:50am, Friday, 21'st Feb 2025
Looking for a good area in which to invest? Consider the healthcare sector.
GILD or VRTX: Which Is the Better Value Stock Right Now?
12:45pm, Thursday, 20'th Feb 2025
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX). But which of these two compani
Vertex to Participate in Upcoming March Investor Conferences
04:05pm, Tuesday, 18'th Feb 2025
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor conferences. Stuart Arbuckle, Executive Vice President a
High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
09:52am, Tuesday, 18'th Feb 2025
Deshawn "DJ" Chow is one of just over 100 sickle cell patients who have undergone treatment with new gene therapies. CVS Health CEO David Joyner said private insurers and employer-sponsored health pla
3 Stocks That Could Trounce the Market in 2025
04:32am, Monday, 17'th Feb 2025
If you're content with market-level returns, investing in an exchange-traded fund (ETF) is the way to go. But if not, you'll need to find stocks that hold the potential to pack more punch.
2 Healthcare Stocks That Tumbled in 2024
08:45am, Saturday, 15'th Feb 2025
Vertex Pharmaceuticals (VRTX -0.77%) and AstraZeneca (AZN -1.17%), two of the world's leading drugmakers, missed last year's strong market rally. Both finished 2024 slightly in the red.
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Friday, 14'th Feb 2025
Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDA
The Ultimate Healthcare Stock to Buy With $500 Right Now
05:47am, Friday, 14'th Feb 2025
Healthcare isn't the hottest sector these days. While the S&P 500 has soared nearly 21% over the last 12 months, healthcare stocks as a group are barely in positive territory.
Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing
04:35am, Friday, 14'th Feb 2025
Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a healthcare stock. It opens up new growth opportunities for the business.
Vertex Pharmaceuticals Incorporated Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - VRTX
07:30am, Thursday, 13'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDA
Vertex Pharmaceuticals Incorporated Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - VRTX
07:30am, Wednesday, 12'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDA
Calls of the Day: Charles Schwab, Vertex Pharma and Transocean
02:21pm, Tuesday, 11'th Feb 2025
The Investment Committee debate the latest Calls of the Day.
VRTX's Q4 Earnings Miss Mark, Revenues Beat on Higher Product Sales
12:01pm, Tuesday, 11'th Feb 2025
Vertex reports mixed fourth-quarter 2024 results as earnings miss estimates while revenues beat the same. Trikafta/Kaftrio drive year-over-year sales.
Vertex: Strong Sales, Stronger Pipeline
09:15am, Tuesday, 11'th Feb 2025
Here's our initial take on Vertex Pharmaceuticals' (VRTX 0.14%) fourth-quarter financial report.
